0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ETAO International Co
Its shares trade under the ticker ETAOF. It has been listed since 17 June 2022. In the fiscal year to 31 December 2023, it reported revenue of $58.1m and a net loss of $896.7m. At that date it held total assets of $53.0m and shareholders' equity of −$15.6m.
ETAO International Co Ltd is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in New York City, New York. The company went IPO on 2022-06-17. ETAO International Co., Ltd. is a digital healthcare company. The firm provides healthcare service, which consist of both online and offline capabilities. The firm offers services, which include online health insurance and pharmacy, digital diabetes management and biotech. Its offline healthcare services consist of hospital and specialty clinics, such as infertility, orthopedic surgery, plastic surgery and primary care. The firm has developed an application for medical consultations delivered online. The company provides services via its end-to-end application solution, to patients by providing access to a network of contracted physicians, pharmacies, and medical supply vendors across various geographical regions to deliver medical consultations, medication, and supplies. The firm provides medical software services to hospitals and/or clinics. The firm delivers medical services and quality care for Chinese patients via telemedicine and other services powered by technology.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 17 Jun 2022
- Employees
- 3,600
- Website
- etao.world ↗
Leadership
Pay as last reported
- Mr. Wensheng LiuChairman of the Board, Chief Executive Officer, Founder, since 2018$200,000
- Mr. Hui WangETAO China Chief Financial Officer, Interim Chief Financial Officer
- Mr. Tao JinETAO China Chief Executive officer
- Mr. Biao DaiIndependent Director$16,800
- Ms. Connie HsuIndependent Director$16,800
- Mr. Zhinan YinIndependent Director
- Mr. Oseas ZuluagaIndependent Director$16,800
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company operates in Health Care sector with 3600 employees.
- Offers both online and offline healthcare services including hospital and specialty clinics.
- Provides end-to-end application solution for medical consultations and supplies.
Weaknesses
- Company is a digital healthcare company with unverified service claims.
- Relies on untrusted source for factual information about services.
- No specific financial data provided for performance evaluation.
Opportunities
- Expanding digital healthcare services to Chinese patients via telemedicine.
- Growing demand for integrated online and offline healthcare solutions.
- Potential for expanding biotech and diabetes management services.
Threats
- Untrusted source may lead to inaccurate public perception of company.
- Competition in digital healthcare sector is intense.
- Dependence on unverified service descriptions could affect credibility.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.